Rationale for pertussis booster vaccination throughout life in Europe. (Q34186477)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21600850 AND SRC:MED&resulttype=core&format=json

1 February 2020

review article

1 reference

title

Rationale for pertussis booster vaccination throughout life in Europe (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21600850 AND SRC:MED&resulttype=core&format=json

1 February 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21600850 AND SRC:MED&resulttype=core&format=json

1 February 2020

Alberto E. Tozzi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21600850 AND SRC:MED&resulttype=core&format=json

1 February 2020

5

Nicole Guiso

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21600850 AND SRC:MED&resulttype=core&format=json

1 February 2020

2

Ulrich Heininger

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21600850 AND SRC:MED&resulttype=core&format=json

1 February 2020

author name string

Fred Zepp

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21600850 AND SRC:MED&resulttype=core&format=json

1 February 2020

Jussi Mertsola

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21600850 AND SRC:MED&resulttype=core&format=json

1 February 2020

John Roord

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21600850 AND SRC:MED&resulttype=core&format=json

1 February 2020

Pierre Van Damme

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21600850 AND SRC:MED&resulttype=core&format=json

1 February 2020

publication date

18 May 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21600850 AND SRC:MED&resulttype=core&format=json

Lancet Infectious Diseases

1 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21600850 AND SRC:MED&resulttype=core&format=json

1 February 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21600850 AND SRC:MED&resulttype=core&format=json

1 February 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21600850 AND SRC:MED&resulttype=core&format=json

1 February 2020

page(s)

557-570

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21600850 AND SRC:MED&resulttype=core&format=json

Duration of immunity against pertussis after natural infection or vaccination

1 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Immunisation and herd immunity

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Estimating the duration of pertussis immunity using epidemiological signatures

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Trends in pertussis among infants in the United States, 1980-1999.

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Resurgence of pertussis in Europe

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Pertussis hospitalizations among infants in the United States, 1993 to 2004.

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Pediatric deaths due to community-acquired bacterial infection. Survey of French pediatric intensive care units

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Morbidity of pertussis in adolescents and adults

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

The role of Bordetella infections in patients with acute exacerbation of chronic bronchitis

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Costs of illness due to Bordetella pertussis in families

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Hospitalization for pertussis: profiles and case costs by age.

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Health and economic consequences of an outbreak of pertussis among healthcare workers in a hospital in France

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Control of pertussis--lessons learnt from a 10-year surveillance programme in Sweden.

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Comparison of pertussis surveillance systems in Europe

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Pediatric sentinel surveillance of vaccine-preventable diseases in Italy

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Pertussis outbreak detected by active surveillance in Cyprus in 2003

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Evidence of Bordetella pertussis infection in adults presenting with persistent cough in a french area with very high whole-cell vaccine coverage

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Transmission of Bordetella pertussis to young infants

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Epidemiology of pertussis

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Multitarget PCR for diagnosis of pertussis and its clinical implications

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Nucleic Acid amplification tests for diagnosis of Bordetella infections

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Proficiency program for real-time PCR diagnosis of Bordetella pertussis infections in French hospital laboratories and at the French National Reference Center for Whooping Cough and other Bordetelloses

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Serologic response and antibody-titer decay in adults with pertussis

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Comparison of five commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Sensitivity and specificity of single IgA and IgG antibody concentrations for early diagnosis of pertussis in adults: an evaluation for outbreak management in public health practice

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Detection of anti-pertussis toxin IgG in oral fluids for use in diagnosis and surveillance of Bordetella pertussis infection in children and young adults

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Natural course of 500 consecutive cases of whooping cough: a general practice population study

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Clinical presentation of pertussis in unvaccinated and vaccinated children in the first six years of life

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Clinical manifestations of Bordetella pertussis infection in immunized children and young adults

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

High incidence of Pertussis among schoolchildren with prolonged cough in Turkey

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys.

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Safety and immunogenicity of a combined DTPa-IPV vaccine administered as a booster from 4 years of age: a review.

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Diphtheria-tetanus-acellular pertussis and inactivated poliovirus vaccines given separately or combined for booster dosing at 4-6 years of age

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Immunogenicity and safety of a combined DTaP-IPV vaccine compared with separate DTaP and IPV vaccines when administered as pre-school booster doses with a second dose of MMR vaccine to healthy children aged 4-6 years

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Immunogenicity and safety of a tetanus toxoid, reduced diphtheria toxoid and three-component acellular pertussis vaccine in adults 19-64 years of age.

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

A randomised controlled trial with a diphtheria-tetanus-acellular pertussis (dTpa) vaccine in adults

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Immunogenicity of a combined diphtheria-tetanus-acellular pertussis vaccine in adults

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Humoral immunity 5 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Booster vaccination of adults with reduced-antigen-content diphtheria, Tetanus and pertussis vaccine: immunogenicity 5 years post-vaccination.

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

High levels of antibody in adults three years after vaccination with a reduced antigen content diphtheria-tetanus-acellular pertussis vaccine.

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Predicted long-term persistence of pertussis antibodies in adolescents after an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine, based on mathematical modeling and 5-year observed data

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Immunogenicity of a single dose of reduced-antigen acellular pertussis vaccine in a non-vaccinated adolescent population

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Infant pertussis: who was the source?

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Prospective Multinational Study of Pertussis Infection in Hospitalized Infants and Their Household Contacts

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Molecular typing of Bordetella pertussis isolates recovered from Belgian children and their household members

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Booster vaccination in the elderly: their success depends on the vaccine type applied earlier in life as well as on pre-vaccination antibody titers

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Pertussis immunization in a high-risk postpartum population

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Adult pertussis vaccination strategies and their impact on pertussis in the United States: evaluation of routine and targeted (cocoon) strategies.

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Adolescent and adult pertussis vaccination: computer simulations of five new strategies

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

What is new in pertussis?

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

The epidemiology of pertussis in Germany: past and present

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Impact of acellular pertussis preschool booster vaccination on disease burden of pertussis in The Netherlands

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine use of vaccination

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

1 reference

7 January 2021

A comparison of pertussis rates in the Northwest Territories: Pre- and postacellular pertussis vaccine introduction in children and adolescents

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Pertussis resurgence in Canada largely caused by a cohort effect

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Pertussis in adolescents: increasing incidence brings attention to the need for booster immunization of adolescents

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Evaluation of strategies for use of acellular pertussis vaccine in adolescents and adults: a cost-benefit analysis

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Pertussis Immunization of Adolescents in the United States

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

How soon after a prior tetanus-diphtheria vaccination can one give adult formulation tetanus-diphtheria-acellular pertussis vaccine?

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Prevention and control of viral hepatitis through adolescent health programmes in Europe

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

[Pertussis: incidence, symptoms and costs]

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Efficacy of an acellular pertussis vaccine among adolescents and adults.

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT).

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Cost-effectiveness of adult pertussis vaccination in Germany

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Safety of Tdap-IPV given one month after Td-IPV booster in healthy young adults: a placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Combined diphtheria-tetanus-pertussis vaccine for tetanus-prone wound management in adults

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Effectiveness of a co-ordinated nation-wide programme to improve influenza immunisation rates in The Netherlands

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

New Pertussis Vaccination Strategies beyond Infancy: Recommendations by the Global Pertussis Initiative

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Prevention of pertussis: Recommendations derived from the second Global Pertussis Initiative roundtable meeting

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Compliance with recommended immunizations in adolescents

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Canadian experience with implementation of an acellular pertussis vaccine booster-dose program in adolescents: implications for the United States

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

Potential strategies to reduce the burden of pertussis

1 reference

https://api.crossref.org/works/10.1016/S1473-3099(11)70007-X

7 January 2021

10.1016/S1473-3099(11)70007-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21600850 AND SRC:MED&resulttype=core&format=json

1 February 2020

1 reference